BioAesthetics‘ is transforming lives through advancements in biomaterials. It has developed NACgraft – an acellular tissue graft for regeneration of the nipple-areolar complex (NAC) for breast cancer/mastectomy patients. NACgraft is clinic-ready and BioAesthetics expects to register with the FDA as an HCT/P and begin sales in 2020.